|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Bipolar transurethral enucleation and resection of the prostate:Whether it is ready to supersede TURP?显示文摘Objective:According to the EAU Guidelines,transurethral resection of the prostate(TURP)has so far still been considered as the gold standard for surgical treatment for patients with obstructing clinical benign prostate hyperplasia(BPH).However,its relatively high rate of complications and postoperative recurrence necessitates further modification and innovation on the surgery technique.We reported the patient outcomes with our technique.Methods:We retrospectively analyzed 52 patients with obstructing clinical BPH who underwent bipolar transurethral enucleation and resection of the prostate(B-TUERP)between March 2015 and September 2015.Pre-and perioperative parameters were obtained from medical charts.Postoperative follow-ups were administrated at 1,3,6,12 and 24 month(s)after surgery,respectively.Results:All the operations were performed successfully with a mean operative time of 43.1 min and an average tissue removal rate of 74.7%.Qmax was significantly improved immediately after surgery,followed by a continuous improvement throughout the follow-ups.Following a steep decrease in mean prostate specific antigen(PSA)and post void residual(PVR)observed within the first half year after surgery,the serum PSA was then maintained at a constant level of 0.61 ng/mL.Temporary urinary retention was found in four cases(7.7%).Stress urinary incontinence occurred in five patients(9.6%),with the condition resolved in 1e2 weeks without extra treatment.Urethral strictures and bladder neck contractures,as the most commonly observed long-term complications,developed in four patients(7.7%).No recurrence was found during 2 years of follow-ups.An improvement in International Index of Erectile Function(IIEF-5)scores was witnessed in 17 patients preoperatively with normal sexual function during the first 6 months after surgery,and sustained throughout the 24-month period.Conclusions:Enucleation reflects an improvement on surgical technique in many ways with a need for surgical equipment that can be broadly accessible in clinical practice.Currently,bipolar resection is a commonly employed procedure in clinical settings,and its similarity shared with bipolar enucleation technique warrants a quick learning of B-TUERP by urologists.Based on these findings,we believe that the substitution of TURP by TUERP as the gold standard for prostate endoscopic procedure can be expected in the future. | Peng Xu Abai Xu Binshen Chen Shaobo Zheng Yawen Xu Hulin Li Haiyan Shen Chunxiao Liu | 2018 | Asian Journal of Urology2018，5，1： | 19 |
| 2 | A Modified Chitosan Adsorbent for Selective Removal of Low Density Lipoprotein显示文摘A modified chitosan adsorbent was synthesized through a simple preparation procedure, and it demonstrated good adsorption performance for selective removal of low density lipoprotein in human plasma. Phase inversion technique was employed to form chitosan beads, to which epoxy groups were then introduced by reacting with ethyleneglycol diglycidylether, and tryptophan was subsequently coupled to the epoxy-activated beads. | GuoQiFU KeYuSHI ZhiYUAN WenQiangNIU BingLinHE BinLIU BinSHEN YanLIU | 2004 | Chinese Chemical Letters2004，15，3： | 3 |
| 3 | An overview of the characteristics of advanced binders for high-performance Li–S batteries显示文摘The lithium-sulfur battery(Li–S)is a promising energy storage system with many advantages over the commercialized lithium-ion battery.It has a high theoretical capacity of 1675 mAh gà1,a high theoretical energy density(2600 Wh kgà1),and is eco-environmentally friendly.Although only a small amount is used(<10 wt%)in the electrode,binders may affect the discharge capacity and cycling stability of sulfur cathodes in the Li–S battery.In recent years,tremendous efforts have been made to develop functional binders with robust adhesive strength,fast ion/electron transportation,strong anchoring of lithium polysulfide(LiPS),and rapid redox kinetics,to improve capacity,coulombic efficiency,and energy density.This article reviews recent developments in binders for the Li–S battery.After briefly introducing the fundamentals of the Li–S battery,the desireable characteristics of binders are discussed based on the correlation between the functions of the binder molecules and the performance of the battery.Future challenges in developing promising binders and potential solutions are provided in the conclusion. | Jun Zhang Mingnan Li Hussein A.Younus Binshen Wang Qunhong Weng Yan Zhang Shiguo Zhang | 2021 | Nano Materials Science2021，3，2： | 2 |
| 4 | Boron based hypergolic ionic liquids:A review显示文摘The advance of space technology is deeply affected by the breakthrough of high-performance fuels.Hypergolic ionic liquids(HILs)are one of the most potential fuels for bipropellant systems.However,high viscosity value and low specific impulse of traditional N-based HILs limit their application.Recently,boron-based HILs with low viscosity become the new candidates,and their derivatives are also found to promote the hypergolicity as additives in HILs.Here,the synthesis,physical chemical properties and thermal performance of boron-based HILs and HILadditive system are reviewed. | Zhenyu Zhang Zirui Zhao Binshen Wang Jiaheng Zhang | 2021 | Green Energy & Environment2021，6，6： | 2 |
| 5 | Percutaneous Nephrolithotomy under Local Infiltration Anesthesia: A Single-Center Experience of 2000 Chinese Cases显示文摘 | Hulin Li Kai Xu Bingkun Li Binshen Chen Abai Xu Yuanbo Chen Yawen Xu Yong Wen Shaobo Zheng Chunxiao Liu | 2013 | Urology2013，，： | 1 |
| 6 | Preparation and Adsorption Properties of PAM Based Adsorbents for Plasma Lipoproteins显示文摘Crosslinked macroporous polyacrylamide (PAM) was prepared with inverse phase suspension polymerization technique.After treatment with hydrazine,the polymer was functionalized with chloroacetic acid,trifluoroacetic acid diethylenetriaminepentaacetic acid (DEPAA),and maleic acid,respectively,and PAM based adsorbents beating carboxyl functional groups for low density lipoprotein (LDL) apheresis use were obtained.The blood compatibility and the adsorption properties for plasma lipoproteins of PAM based adsorbents were investigated. | HaiTaoLI ZhiYUAN XinFuCHEN BinLIU BinSHEN BingLinHE | 2004 | Chinese Chemical Letters2004，15，4： | 1 |
| 7 | Synthesis of Bis-benzimidazolium Cyclic Receptors and Their Anion Binding Properties显示文摘15 基于 bis-benzimidazolium 组织的一系列周期的受体被设计并且综合。他们的阴离子识别性质被调查由紫外力,荧光灯光谱学, 1H NMR 和 MALDI-TOF 集体 spectrometry。紫外力、荧光灯的分光镜的研究证明受体为象氟化物,氯化物,溴化物,碘化物和醋酸盐那样的各种各样的阴离子的 15 个有的不同有约束力的能力。为氟化物和醋酸盐阴离子的受体的高选择被归因于他们的盐基度。工作阴谋和 MALDI-TOF 团 spectrometry 证明受体形成与氟化物复杂的 1:1。DFT 计算和 1H NMR 研究显示受体绑阴离子通过(CH )+?? X 氢债券。 | Xiaozhi Jiang Meiyun Feng Dawei Zhang Binshen Wang Zhiyun Dong Guohua Gao | 2013 | Chinese Journal of Chemistry2013，31，5： | 1 |
| 8 | Etoposide,dexamethasone,and pegaspargase with sandwiched radiotherapy in early-stage natural killer/T-cell lymphoma:A randomized phase III study显示文摘Methotrexate,etoposide,dexamethasone,and pegaspargase(MESA)with sandwiched radiotherapy is known to be effective for early-stage extranodal natural killer/T-cell lymphoma,nasal type(NKTCL).We explored the efficacy and safety of reduced-intensity,non-intravenous etoposide,dexamethasone,and pegaspargase(ESA)with sandwiched radiotherapy.This multicenter,randomized,phase III trial enrolled patients aged between 14 and 70 years with newly diagnosed early-stage nasal NKTCL from 27 centers in China.Patients were randomly assigned(1:1)to receive ESA(pegaspargase 2,500 IU/m^(2)intramuscularly on day 1,etoposide 200 mg orally,and dexamethasone 40 mg orally on days 2–4)or MESA(methotrexate 1 g/m^(2)intravenously on day 1,etoposide 200 mg orally,and dexamethasone 40 mg orally on days 2–4,and pegaspargase 2,500 IU/m^(2)intramuscularly on day 5)regimen(four cycles),combined with sandwiched radiotherapy. | Huijuan Zhong Shu Cheng Xi Zhang Bing Xu Jiayi Chen Xufeng Jiang Jie Xiong Yu Hu Guohui Cui Juying Wei Wenbin Qian Xiaobing Huang Ming Hou Feng Yan Xin Wang Yongping Song Jianda Hu Yuanhua Liu Xuejun Ma Fei Li Chongyang Wu Junmin Chen Li Yu Ou Bai Jingyan Xu Zunmin Zhu Li Liu Xin Zhou Li Huang Yin Tong Ting Niu Depei Wu Hao Zhang Chaofu Wang Binshen Ouyang Hongmei Yi Qi Song Gang Cai Biao Li Jia Liu Zhifeng Li Rong Xiao Luqun Wang Yujie Jiang Yanyan Liu Xiaoyun Zheng Pengpeng Xu Hengye Huang Li Wang Saijuan Chen Weili Zhao | 2023 | The Innovation2023，4，3： | 0 |
| 9 | Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma显示文摘Autoimmune diseases (ADs) increase the risk of non-Hodgkin's lymphoma and contribute to poor prognosis of patients. However, the association between immunologic markers and clinical outcome has rarely been investigated. This study aims to analyze the prognostic value of pretreatment immunologic markers in newly diagnosed patients with diffuse large B-cell lymphoma (DLBCL). We retrospectively reviewed the data on 502 patients with DLBCL treated in our institution from January 2013 to March 2018. Survival functions were estimated using Kaplan Meier method and Cox regression model. The 3-year progression free survival (PFS) and overall survival (OS) rates were 70.2% and 80.9%, respectively, and the complete remission (CR) rate was 78.1%. Among the patients, those with multiple (≥3) abnormal immunologic markers had significantly shorter 3-year PFS (52.7% vs. 77.3%, P < 0.001) and OS (68.5% vs. 85.8%, P=0.001) than those without multiple abnormal immunologic markers.Multivariate analysis revealed that the presence of multiple abnormal immunologic markers and the elevated serum levels of lactate dehydrogenase were the independent adverse prognostic factors for PFS (P= 0.008, P < 0.001) and OS (P = 0.003, P < 0.001). Meanwhile, advanced Ann Arbor stage was an independent adverse prognostic factor for PFS (P= 0.001) and age > 60 years for OS (P= 0.014). In conclusion, the immunologic status was closely related to lymphoma progression, and this study provides new insights into the risk stratification of patients with DLBCL. | Yiwen Cao Zhenhua Liu Wen Wu Ying Qian Qin Shi Rong Shen Binshen Ouyang Pengpeng Xu Shu Cheng Jin Ye Yiming Lu Chaofu Wang Chengde Yang Li Wang Weili Zhao | 2019 | Frontiers of Medicine2019，13，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员